Aldisa Junior Dosage & Drug Information

Concise Prescribing Info Bahasa Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Warnings Special Precautions Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Per 5 mL Pseudoephedrine HCl 15 mg, chlorpheniramine maleate 1 mg

Indications/Uses

Relieves sneezing, nasal congestion due to common cold.

Click to view Aldisa Junior detailed prescribing information

Dosage/Direction for Use

Adult & childn >12 yr 10 mL 3 times daily, 6-12 yr 5 mL 3 times daily, 2-5 yr 2.5 mL 3 times daily.

Click to view Aldisa Junior detailed prescribing information

Contraindications

Hypersensitivity to other sympathomimetic drugs (eg, ephedrine, phenylpropanolamine HCl, phenylephrine). Severe HTN or uncontrolled high BP. Concomitant MAOI antidepressant therapy. Severe acute & CKD or w/ kidney failure.

Click to view Aldisa Junior detailed prescribing information

Warnings

For additional cautionary notes to warn of the potential risk of using the medicine... Click to view Aldisa Junior detailed prescribing information

Special Precautions

Discontinue use if the patient experience insomnia, palpitation, dizziness. Glaucoma, prostate hypertrophy, hyperthyroidism, urinary retention, heart disorders, DM. Concomitant use w/ other CNS depressants. Patients w/ or potential to develop HTN or stroke eg, overwt. May impair ability to drive or operate machinery. Liver & kidney dysfunction. Not recommended in pregnancy & nursing women. Not recommended in childn <2 yr. Elderly. Pseudoephedrine: Discontinue use if posterior reversible encephalopathy & reversible cerebral vasoconstriction syndrome occur.

Click to view Aldisa Junior detailed prescribing information

Adverse Reactions

Insomnia, headache, excitation, tremor, tachycardia, arrhythmia, palpitation, urination difficulty, & GI disturbance. Nausea, vomiting, confusion, seizures &/or visual disturbances. Chlorpheniramine: Drowsiness & dry mouth.

Click to view Aldisa Junior detailed prescribing information

Drug Interactions

May cause hypertensive crisis w/ MAOI antidepressant. Central-acting agents (sympathomimetics, antidepressants) may be increased by pseudoephedrine HCl or chlorpheniramine.

Click to view Aldisa Junior detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Aldisa Junior detailed prescribing information

Storage

View Aldisa Junior storage conditions for details to ensure optimal shelf-life.

Description

View Aldisa Junior description for details of the chemical structure and excipients (inactive components).

Action

View Aldisa Junior mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Cough & Cold Preparations

ATC Classification

R01BA52 - pseudoephedrine, combinations ; Belongs to the class of systemic sympathomimetic preparations used as nasal decongestants.

Regulatory Classification

Presentation/Packing

Form

Aldisa Junior syr

Packing/Price

60 mL x 1's

Aldisa Junior

Manufacturer:

Sanbe